HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Antibody pattern in patients with different forms of leishmaniasis (author's transl)].

Abstract
Using the indirect fluorescent antibody test, leishmanial antibodies could be demonstrated in patients with Leishmaniasis. In 18 of 22 cases of kala-azar the titers ranged between 1:160 and 1:1280. In the complement fixation test the titers in patients with kala-azar varied between greater than 1:4 in one case and less than or equal to 1:512 in twelve of the 22 patients. Complement fixing antibodies could not be detected in five of the nine patients with cutaneous or mucocutaneous leishmaniasis. The indirect haemagglutination test proved to be not suitable for diagnostic purposes because it did not detect antibodies in nine out of 22 cases with kala-azar. The IgG fraction of the serum immunoglobulins was increased in most patients with kala-azar. Sensitivity and specificity of the three immunological methods are discussed with reference to the results in 832 undefined sera submitted for routine diagnosis.
AuthorsE Mannweiler, I Lederer, I zum Felde
JournalZentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie (Zentralbl Bakteriol Orig A) Vol. 240 Issue 3 Pg. 397-402 (Apr 1978) ISSN: 0300-9688 [Print] Germany
Vernacular TitleDas Antikörperbild bei Patienten mit Leishmaniosen.
PMID352039 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies
Topics
  • Antibodies (analysis)
  • Antibody Formation
  • Humans
  • Immunologic Techniques
  • Leishmaniasis (immunology)
  • Leishmaniasis, Visceral (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: